Effects of captopril on plasma endothelin-1 during thrombolysis: preliminary findings.
Di Pasquale
P
P
Paterna
S
S
Parrinello
G
G
Bucca
V
V
Caracausi
R
R
Pipitone
F
F
Licata
G
G
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology* / Q000627:therapeutic use; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D016232:Endothelins / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
D016232:Endothelins; D011994:Recombinant Proteins; D002216:Captopril; D010959:Tissue Plasminogen Activator; D008790:Metoprolol